Literature DB >> 18647740

The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prostheses.

Peter A Revell1.   

Abstract

This review considers the causes of loosening of prosthetic joint replacement paying attention to the biological mechanisms rather than other effects that are physical, such as component fracture and other failure related to mechanical problems. Infection accounts for approximately 1.5 per cent of joint loosening and when it occurs it is a cause of serious concern to the surgeon. The loosening of prosthetic joints in the absence of infection is by far the most common reason for revision surgery and is known as aseptic loosening. While this may be multifactorial in terms of causation, and non-biological factors may contribute significantly in a particular individual, a significant part is undoubtedly played by the generation of wear debris, mainly from the bearing surfaces of the joint, and the cellular reaction to this in the implant bed. Phagocytic cells (macrophages and multinucleated giant cells) are the ones that remove foreign material from the tissues, and the ways in which these cells function in the interface between implant and bone are described. Mediators produced locally include numerous cytokines, enzymes and integrins. There is evidence for interactions between macrophages and locally recruited lymphocytes, which may or may not give rise to an immunologically mediated process.Sensitization of individuals having metal implants in place has been shown by positive skin tests or blood lymphocyte transformation tests and in these cases has been accompanied by loosening and failure of the replacement joint. The question remains as to whether this process is also present in a proportion of individuals with aseptic loosening in the absence of clearly defined clinical evidence of sensitization.Numerous studies performed by the author's group and, latterly, by others suggest that the cellular reactions detected in the tissues in cases of aseptic loosening are indeed those of contact sensitization. There is good evidence to show that a type IV cell-mediated immune reaction is taking place, with TH1 cell involvement and active antigen presentation. The extent to which sensitization is present in individual cases of aseptic loosening remains a subject for further work and this needs all the sophisticated molecular methods now available to modern biology to be applied in appropriate prospective clinical studies coupled with experimental models in vitro and in vivo. Immunological processes may play a more important part in joint loosening than previously considered.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18647740      PMCID: PMC2607446          DOI: 10.1098/rsif.2008.0142

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  106 in total

1.  Debris from failed ceramic-on-ceramic and ceramic-on-polyethylene hip prostheses.

Authors:  Y Mochida; M Boehler; M Salzer; T W Bauer
Journal:  Clin Orthop Relat Res       Date:  2001-08       Impact factor: 4.176

2.  Early osteolysis following second-generation metal-on-metal hip replacement.

Authors:  Youn-Soo Park; Young-Wan Moon; Seung-Jae Lim; Jun-Mo Yang; Geunghwan Ahn; Yoon-La Choi
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

3.  Neovascularisation and the induction of cell adhesion molecules in response to degradation products from orthopaedic implants.

Authors:  N al-Saffar; J T Mah; Y Kadoya; P A Revell
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

4.  Type IV collagen and laminin in the synovial intimal layer: an immunohistochemical study.

Authors:  L E Pollock; P Lalor; P A Revell
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

Review 5.  Extracellular matrix of the synovial intimal cell layer.

Authors:  P A Revell; N al-Saffar; S Fish; D Osei
Journal:  Ann Rheum Dis       Date:  1995-05       Impact factor: 19.103

6.  Regional dissemination of wear debris from a total knee prosthesis. A case report.

Authors:  T W Bauer; M Saltarelli; J T McMahon; A H Wilde
Journal:  J Bone Joint Surg Am       Date:  1993-01       Impact factor: 5.284

7.  "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening.

Authors:  T A Gruen; G M McNeice; H C Amstutz
Journal:  Clin Orthop Relat Res       Date:  1979-06       Impact factor: 4.176

8.  Widespread dissemination of metal debris from implants.

Authors:  C P Case; V G Langkamer; C James; M R Palmer; A J Kemp; P F Heap; L Solomon
Journal:  J Bone Joint Surg Br       Date:  1994-09

9.  The characterization of cytokines in the interface tissue obtained from failed cementless total hip arthroplasty with and without femoral osteolysis.

Authors:  J Chiba; H E Rubash; K J Kim; Y Iwaki
Journal:  Clin Orthop Relat Res       Date:  1994-03       Impact factor: 4.176

10.  Characterisation of wear particles produced by metal on metal and ceramic on metal hip prostheses under standard and microseparation simulation.

Authors:  Christopher Brown; Sophie Williams; Joanne L Tipper; John Fisher; Eileen Ingham
Journal:  J Mater Sci Mater Med       Date:  2006-12-14       Impact factor: 4.727

View more
  45 in total

1.  Surface damage versus tibial polyethylene insert conformity: a retrieval study.

Authors:  Markus A Wimmer; Michel P Laurent; Jeannie D Haman; Joshua J Jacobs; Jorge O Galante
Journal:  Clin Orthop Relat Res       Date:  2012-07       Impact factor: 4.176

Review 2.  The role of lymphocyte proliferation tests in assessing occupational sensitization and disease.

Authors:  Stella E Hines; Karin Pacheco; Lisa A Maier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-04

3.  Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles.

Authors:  Christine A St Pierre; Melvin Chan; Yoichiro Iwakura; David C Ayers; Evelyn A Kurt-Jones; Robert W Finberg
Journal:  J Orthop Res       Date:  2010-11       Impact factor: 3.494

4.  Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles.

Authors:  Zhenyu Yao; Michael Keeney; Tzu-Hua Lin; Jukka Pajarinen; Katherine Barcay; Heather Waters; Kensuke Egashira; Fan Yang; Stuart Goodman
Journal:  J Biomed Mater Res A       Date:  2013-11-20       Impact factor: 4.396

5.  Exogenous MC3T3 preosteoblasts migrate systemically and mitigate the adverse effects of wear particles.

Authors:  Kate Fritton; Pei-Gen Ren; Emmanuel Gibon; Allison J Rao; Ting Ma; Sandip Biswal; Sanjiv S Gambhir; Stuart B Goodman
Journal:  Tissue Eng Part A       Date:  2012-08-14       Impact factor: 3.845

6.  Lateral tibial plateau autograft in revision surgery for failed medial unicompartmental knee arthroplasty.

Authors:  Simone Cerciello; Brent Joseph Morris; Sebastien Lustig; Enrico Visonà; Giuliano Cerciello; Katia Corona; Philippe Neyret
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-04-24       Impact factor: 4.342

7.  Local delivery of mutant CCL2 protein-reduced orthopaedic implant wear particle-induced osteolysis and inflammation in vivo.

Authors:  Xinyi Jiang; Taishi Sato; Zhenyu Yao; Michael Keeney; Jukka Pajarinen; Tzu-Hua Lin; Florence Loi; Kensuke Egashira; Stuart Goodman; Fan Yang
Journal:  J Orthop Res       Date:  2015-07-29       Impact factor: 3.494

8.  In vivo wear of a squeaky alumina-on-alumina hip prosthesis: a case report.

Authors:  Michel P Laurent; Robin Pourzal; Alfons Fischer; Kim C Bertin; Joshua J Jacobs; Markus A Wimmer
Journal:  J Bone Joint Surg Am       Date:  2011-04-06       Impact factor: 5.284

Review 9.  Pathogenesis of implant-associated infection: the role of the host.

Authors:  Werner Zimmerli; Parham Sendi
Journal:  Semin Immunopathol       Date:  2011-05-21       Impact factor: 9.623

10.  Biological activity and migration of wear particles in the knee joint: an in vivo comparison of six different polyethylene materials.

Authors:  S Utzschneider; V Lorber; M Dedic; A C Paulus; C Schröder; O Gottschalk; M Schmitt-Sody; V Jansson
Journal:  J Mater Sci Mater Med       Date:  2014-02-22       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.